NDC 65862-290

Ribavirin

Ribavirin

Ribavirin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is Ribavirin.

Product ID65862-290_8621e186-69ae-46cd-bd4b-a033219a03c1
NDC65862-290
Product TypeHuman Prescription Drug
Proprietary NameRibavirin
Generic NameRibavirin
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2009-09-17
Marketing CategoryANDA / ANDA
Application NumberANDA079117
Labeler NameAurobindo Pharma Limited
Substance NameRIBAVIRIN
Active Ingredient Strength200 mg/1
Pharm ClassesNucleoside Analog [EXT],Nucleoside Analog Antiviral [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 65862-290-05

500 CAPSULE in 1 BOTTLE (65862-290-05)
Marketing Start Date2009-09-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 65862-290-42 [65862029042]

Ribavirin CAPSULE
Marketing CategoryANDA
Application NumberANDA079117
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-09-17

NDC 65862-290-18 [65862029018]

Ribavirin CAPSULE
Marketing CategoryANDA
Application NumberANDA079117
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-09-17

NDC 65862-290-05 [65862029005]

Ribavirin CAPSULE
Marketing CategoryANDA
Application NumberANDA079117
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-09-17

NDC 65862-290-56 [65862029056]

Ribavirin CAPSULE
Marketing CategoryANDA
Application NumberANDA079117
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-09-17

NDC 65862-290-84 [65862029084]

Ribavirin CAPSULE
Marketing CategoryANDA
Application NumberANDA079117
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-09-17

NDC 65862-290-70 [65862029070]

Ribavirin CAPSULE
Marketing CategoryANDA
Application NumberANDA079117
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-09-17

Drug Details

Active Ingredients

IngredientStrength
RIBAVIRIN200 mg/1

OpenFDA Data

SPL SET ID:35f99f76-f2ef-4a81-91ff-285419664be3
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 312817
  • Pharmacological Class

    • Nucleoside Analog [EXT]
    • Nucleoside Analog Antiviral [EPC]

    Medicade Reported Pricing

    65862029084 RIBAVIRIN 200 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    65862029070 RIBAVIRIN 200 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    65862029056 RIBAVIRIN 200 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    65862029042 RIBAVIRIN 200 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    65862029018 RIBAVIRIN 200 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Ribavirin" or generic name "Ribavirin"

    NDCBrand NameGeneric Name
    0781-2043RibavirinRibavirin
    0781-5177RibavirinRibavirin
    42494-423RibavirinRibavirin
    53808-0781RibavirinRIBAVIRIN
    53808-0782RibavirinRIBAVIRIN
    54738-950ribavirinribavirin
    54738-951ribavirinribavirin
    54738-952ribavirinribavirin
    54738-953ribavirinribavirin
    63629-2149RibavirinRibavirin
    65841-046RibavirinRibavirin
    65841-129RibavirinRibavirin
    65841-260RibavirinRibavirin
    65841-603RibavirinRibavirin
    65841-632RibavirinRibavirin
    65862-207RibavirinRibavirin
    68084-179RibavirinRibavirin
    68382-046RibavirinRibavirin
    68382-260RibavirinRibavirin
    68382-129RibavirinRibavirin
    68382-128RibavirinRibavirin
    68382-395RIBAVIRINRIBAVIRIN
    68382-127RibavirinRibavirin
    68682-019RibavirinRibavirin
    65862-290RibavirinRibavirin
    68475-003RIBAVIRINRIBAVIRIN
    0074-3197ModeribaRibavirin
    0074-3282ModeribaRibavirin
    0085-1318REBETOLribavirin
    0187-0007VirazoleRibavirin

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.